Synthesis and evaluation of α-aminoacyl amides as antitubercular agents effective on drug resistant tuberculosis.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
15 Feb 2019
Historique:
received: 20 09 2018
revised: 30 12 2018
accepted: 01 01 2019
pubmed: 18 1 2019
medline: 7 3 2019
entrez: 18 1 2019
Statut: ppublish

Résumé

The development of an effective antitubercular agent is a challenge due to the complex nature of tuberculosis. Herein, we report the synthesis and evaluation of α-aminoacyl amides as antitubercular agents. The systematic medicinal chemistry approach led to identification of optimal substitutions required for the activity. Compound 11l was identified as antitubercular lead with drug like properties. Further, 11l selectively inhibited M. tuberculosis H37Rv with MIC value of 0.78 μM and was found to be non-toxic to CHOK1 cells. The lead compound inhibited multidrug resistant and Pre-Extensively drug resistant strains of Mycobacterium at 2 μg/mL and 8 μg/mL respectively.

Identifiants

pubmed: 30654238
pii: S0223-5234(19)30002-9
doi: 10.1016/j.ejmech.2019.01.002
pii:
doi:

Substances chimiques

Amides 0
Antitubercular Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

665-677

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Vitthal B Makane (VB)

Department of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India.

Vagolu Siva Krishna (VS)

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, R.R. District, Hyderabad, 500 078, India.

E Vamshi Krishna (EV)

Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India; Department of Biology, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.

Manjulika Shukla (M)

Department of Microbiology, CSIR-Central Drug Research Institute, Lucknow, 226021, Uttar Pradesh, India.

B Mahizhaveni (B)

Department of Bacteriology, National Institute for Research in Tuberculosis, Chennai, India.

Sunil Misra (S)

Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India; Department of Biology, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India.

Sidharth Chopra (S)

Department of Microbiology, CSIR-Central Drug Research Institute, Lucknow, 226021, Uttar Pradesh, India.

Dharmarajan Sriram (D)

Department of Pharmacy, Birla Institute of Technology & Science-Pilani, Hyderabad Campus, Jawahar Nagar, Shameerpet Mandal, R.R. District, Hyderabad, 500 078, India.

V N Azger Dusthackeer (VNA)

Department of Bacteriology, National Institute for Research in Tuberculosis, Chennai, India.

Haridas B Rode (HB)

Department of Organic Synthesis and Process Chemistry, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad, 500 007, India; Academy of Scientific and Innovative Research, Ghaziabad, Uttar Pradesh, 201 002, India. Electronic address: haridas.rode@iict.res.in.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH